Literature DB >> 15522450

Selection and characterization of peptides specifically binding to HIV-1 psi (psi) RNA.

Mi Young Park1, Jiyeon Kwon, Sangyoon Lee, Jichang You, Heejoon Myung.   

Abstract

The packaging of HIV genomic RNA is mediated by a specific interaction between a nucleocapsid (NC) protein and packaging signal (psi, psi) RNA sequence. However, this interaction can be inhibited by the presence of peptides or proteins that specifically bind to the psi sequence. The 125-base-long psi RNA comprises a specific secondary structure that can be recognized by certain peptide sequences. Accordingly, the current study presents a method for selecting such peptides from a phage-displayed peptide library and characterization of resulting peptides in vitro. The RNA was covalently immobilized in a Covalink module using a carbodiimide condensation reaction at its 5'-end, leaving the proper secondary structure exposed and readily accessible. A phage display random peptide library was then screened against the RNA structure, and after five rounds of biopanning, enriched peptide sequences and conserved amino acid frames appeared. One of the enriched peptides was tested and shown to bind to psi RNA in a dose-dependent manner, plus it competed effectively with the NC protein as regards binding with the target RNA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15522450     DOI: 10.1016/j.virusres.2004.05.012

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  6 in total

Review 1.  Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy.

Authors:  Divita Garg; Bruce E Torbett
Journal:  Virus Res       Date:  2014-07-12       Impact factor: 3.303

Review 2.  HIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors.

Authors:  Paul Spearman
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

3.  The N-terminal zinc finger and flanking basic domains represent the minimal region of the human immunodeficiency virus type-1 nucleocapsid protein for targeting chaperone function.

Authors:  Mithun Mitra; Wei Wang; My-Nuong Vo; Ioulia Rouzina; George Barany; Karin Musier-Forsyth
Journal:  Biochemistry       Date:  2013-11-06       Impact factor: 3.162

Review 4.  Phages and HIV-1: from display to interplay.

Authors:  Sylvie Delhalle; Jean-Claude Schmit; Andy Chevigné
Journal:  Int J Mol Sci       Date:  2012-04-13       Impact factor: 6.208

5.  Inhibitory effects of archetypical nucleic acid ligands on the interactions of HIV-1 nucleocapsid protein with elements of Psi-RNA.

Authors:  Kevin B Turner; Nathan A Hagan; Daniele Fabris
Journal:  Nucleic Acids Res       Date:  2006-03-06       Impact factor: 16.971

Review 6.  Current Peptide and Protein Candidates Challenging HIV Therapy beyond the Vaccine Era.

Authors:  Koollawat Chupradit; Sutpirat Moonmuang; Sawitree Nangola; Kuntida Kitidee; Umpa Yasamut; Marylène Mougel; Chatchai Tayapiwatana
Journal:  Viruses       Date:  2017-09-29       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.